Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U7 snRNA-associated Sm-like protein LSM10 (LSM10) is a specialized Sm-like protein that is uniquely incorporated into the U7 small nuclear ribonucleoprotein (snRNP) complex responsible for the 3′-end processing of replication-dependent histone pre-mRNAs[1][2][3]. Unlike canonical spliceosomal snRNPs, U7 snRNP contains LSM10 and LSM11, which together replace the typical SmD1 and SmD2 proteins of the Sm core ring. The presence of LSM10 is dictated by the unique Sm-binding site of U7 snRNA, and its assembly into the U7 snRNP is essential for proper localization (Cajal bodies, histone locus bodies) and function in histone mRNA processing, thereby regulating cell cycle progression[1][2][3][4]. Knockdown or mutation of LSM10 disrupts histone mRNA maturation and cell cycle control[1][4].
Not applicable (no drug mechanism reported; LSM10 itself enables binding of U7 snRNA and participates in the formation and function of U7 snRNP)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U7 snRNA-associated Sm-like protein LSM10 (LSM10).